← Back to headlines
U.S. Court Orders Guardant to Pay $245 Million in Patent Dispute
A U.S. court has ruled that Guardant must pay $245 million in damages as part of a DNA sequencing patent dispute, concluding a significant legal battle.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.


